Published data indicate that FABP3 is critical for preventing synucleinopathies; therefore, its downregulation in cells harboring the m.13513G>A variant could lead to impaired alpha-synuclein uptake and formation of aggregates [77]. This evidence concerns the gene FABP3 and synucleinopathy.